Finance

Lists
Why is MDXG down 2.29%?
Dive Deeper
MDXG:NASDAQ
MiMedx Group Inc
$3.20
-2.29%
(-0.075) 1D
Nov 3, 11:28:39 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDXG...
Open
$3.27
High
$3.30
Low
$3.20
Mkt. cap
467.69M
Avg. vol.
1.47M
Volume
247.33K
52-wk high
$7.97
52-wk low
$3.02
EPS
-$0.13
Beta
1.17
Shares outstanding
145.93M
No. of employees
808
Open
$3.27
High
$3.30
Low
$3.20
Mkt. cap
467.69M
Avg. vol.
1.47M
Volume
247.33K
52-wk high
$7.97
52-wk low
$3.02
EPS
-$0.13
Beta
1.17
Shares outstanding
145.93M
No. of employees
808
News stories
From web sources and news partners
About MiMedx Group Inc
CEOTimothy R Wright
Employees808
Founded2006
HeadquartersMarietta, Georgia, United States
SectorBiotechnology
Websitemimedx.com
Analyst ratings
Based on 4 analysts giving stock ratings to MDXG in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MDXG in the last 3 months.
Highest
Current $3.20
$8.00 (+149.61%)
Average
$7.25 (+126.21%)
Lowest
$7.00 (+118.41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
$7.00
+118.4%
10/29/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$7.00
+118.4%
10/29/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$7.00
+118.4%
10/01/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Reiterated
$8.00
+149.6%
08/17/2026
Brooks O'Neil
Lake Street
Buy
Maintained
$5.00
+56%
04/30/2026
David Turkaly
Citizens JMP
Buy
Maintained
$6.00
+87.2%
04/30/2026
Carl Byrnes
Northland Securities
Buy
Maintained
$6.00
+87.2%
04/17/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
$8.00
+149.6%
02/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
118.10M
58.99M
64.36M
62.28M
Cost of goods sold
19.06M
17.37M
19.98M
12.58M
Cost of revenue
19.06M
17.37M
19.98M
12.58M
Research and development expenses
4.76M
4.14M
2.78M
2.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73.07M
53.23M
59.78M
58.31M
Operating expense
77.96M
57.67M
62.85M
61.40M
Total operating expenses
97.02M
75.04M
82.83M
73.98M
Operating income
21.08M
-16.05M
-18.47M
-11.70M
Other non operating income
-186.00K
-168.00K
-102.00K
-136.00K
EBT including unusual items
21.80M
-15.33M
-17.78M
-11.06M
EBT excluding unusual items
21.80M
-15.33M
-17.78M
-11.06M
Income tax expense
6.60M
-4.47M
-2.94M
-2.38M
Effective tax rate
30.30%
29.16%
16.54%
21.51%
Other operating expenses
-
-
-
-
Net income
15.19M
-10.86M
-14.84M
-8.68M
Net profit margin
12.86%
-18.41%
-23.06%
-13.94%
Earnings per share
0.14
-0.05
-0.05
-0.01
Interest and investment income
1.31M
1.29M
1.17M
986.00K
Interest expense
-405.00K
-402.00K
-386.00K
-210.00K
Net interest expenses
904.00K
886.00K
788.00K
776.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
24.30M
-14.43M
-16.94M
-10.24M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps